Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002117918 | SCV002402579 | benign | not provided | 2024-01-14 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002486897 | SCV002797522 | likely benign | Hypertriglyceridemia 2 | 2021-11-02 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV002117918 | SCV005309575 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004758216 | SCV005345495 | likely benign | CREB3L3-related disorder | 2024-04-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |